The Role of Real-World Evidence in Regulatory Decision-Making Moderator: Mark McClellan, MD, PhD, Director, Duke-Margolis Center for Health Policy and Robert J. Margolis Professor of Business, Medicine, and Policy Nancy […]
Webinars
Optimizing Digital Health Trials by Engaging Patients and Sites
Register now for this webinar on Jan. 12 at 2 p.m. Speakers include, Virginia Nido, Global Head, Product Development Industry Collaborations, Genentech; and Cindy Geoghegan, Patient Advocate.
Current Landscape of Patient-Generated Data and Data Privacy
Current Landscape of Patient-Generated Data and Data Privacy Moderator: Elisabeth M. Oehrlein, PhD, MS, Senior Director, Research & Programs, National Health Council Craig Lipset, Advisor and Founder, Clinical Innovation Partners […]
Multi-Criteria Decision Analysis: Can It Help Make Value Assessment More Patient-Centered?
Join us on Nov. 19 from 11:00 a.m. – 12:00 p.m. ET for a webinar, held in tandem with release of a white paper summarizing findings from a Roundtable on Patient-Centered Multi-Criteria Decision Analysis (MCDA), co-hosted by the NHC and National Pharmaceutical Council earlier this year. Speakers will introduce MCDA and describe comments, suggestions, and takeaways that emerged during the discussion.
Sources of RWD: An Introduction to Patient Registries
Sources of RWD: An Introduction to Patient Registries Moderator: Elisabeth Oehrlein, PhD, MS, Senior Director, Research & Programs, National Health Council Robert McBurney, PhD, Chief Research Officer, Accelerated Cure Project for Multiple Sclerosis […]
Sources of RWD: An Introduction to “Big Data”
This webinar will introduce big data, an umbrella term used to describe some types of real-world data. Big data can come from health care visits, including information from electronic health records and insurance claims, and it also can come from “non-traditional” sources such as social media and wearable devices.
Real-World Data and Real-World Evidence 101
This webinar will introduce essential terminology related to real-world data (RWD) and real-world evidence (RWE). We will discuss how RWE complements evidence from traditional randomized clinical trials and highlight case examples.
Health Literacy Throughout Drug Development: Why it Matters to Pharma and to Patients
Health Literacy Throughout Drug Development: Why it Matters to Pharma and to Patients Patient-Focused Medical Product Development (PFMPD) Webinar Series Speaker: Laurie Myers, MBA, Global Health Literacy Director, Merck https://youtu.be/ALm9FF_g0v8 […]
Patient-Focused Medical Product Development: Real-World Case Examples
Patient-Focused Medical Product Development: Real-World Case Examples August’s webinar, “Real-World Case Examples” highlights real-life, patient-focused drug development examples from medical product companies. Speakers: Trisha Devlin, Sr. Director of Patient Value, […]
NHC Fair-Market Value Calculator Demonstration Webinar
NHC Fair-Market Value Calculator Demonstration Webinar This new online FMV calculator can be used to determine compensation for patients, caregivers, and patient groups involved in “patient engagement activities” taking place […]